News 18.08.2026 Schlieren, Switzerland – August 17, 2026 The combined leadership role will strengthen operational excellence, digitalization, and technology development as InSphero continues to grow and scale its organization. InSphero AG today announced the promotion of Olivier Frey, PhD, to the combined role of Chief Operating Officer (COO) and Chief Technology Officer (CTO). Previously Vice...
News 14.08.2026 Boehringer Ingelheim has acquired Evax AG, a Swiss biotech company focused on therapeutic vaccines to address significant unmet needs in horses, particularly for the treatment of allergic skin diseases. Allergies and dermatologic conditions in horses are common and have a significant impact on their health and well-being yet are very challenging to treat....
News 13.08.2026 Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability Schlieren (Zurich), Switzerland, August 13, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial and operational results for the first half of 2026. Financial Highlights Total Medical Device sales...
News 10.08.2026 CINCINNATI, Ohio , Aug. 05, 2026 (GLOBE NEWSWIRE) — Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) today announced that its fully-owned Swiss subsidiary, Proteomedix AG (“PMX”), has appointed Ralph Schiess, PhD to the PMX Board of Directors. The appointment was approved at the PMX Annual General Meeting of Shareholders held...
News 30.07.2026 DINMIQS is welcoming Sabine Kuratli. Sabine joined at the beginning of this month as our new Head of Manufacturing & MSAT. With more than 20 years of experience in biopharmaceutical development, GMP manufacturing and Manufacturing Science & Technology (MSAT), Sabine brings extensive expertise in developing and executing CMC strategies, process development, technology...